Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,126 | 205 | 98.8% |
| Education | $26.04 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $385.18 | 38 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $329.18 | 49 | $0 (2019) |
| GlaxoSmithKline, LLC. | $287.17 | 24 | $0 (2019) |
| PFIZER INC. | $160.53 | 16 | $0 (2019) |
| Novo Nordisk Inc | $153.57 | 14 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $137.53 | 10 | $0 (2018) |
| Amgen Inc. | $121.58 | 10 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $61.58 | 5 | $0 (2018) |
| Astellas Pharma US Inc | $57.17 | 4 | $0 (2019) |
| Lilly USA, LLC | $54.40 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $118.73 | 9 | PFIZER INC. ($34.55) |
| 2018 | $621.41 | 62 | Janssen Pharmaceuticals, Inc ($155.34) |
| 2017 | $1,412 | 136 | Allergan Inc. ($236.00) |
All Payment Transactions
207 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Lower GI | ||||||
| 01/31/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/10/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: UROLOGY | ||||||
| 01/07/2019 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2018 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Neuroscience | ||||||
| 12/04/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Endocrinology | ||||||
| 12/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Diabetes | ||||||
| 11/27/2018 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Neuroscience | ||||||
| 11/16/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Central Nervous System | ||||||
| 10/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/01/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Endocrinology | ||||||
| 09/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/13/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 321 | 438 | $61,639 | $27,054 |
| 2022 | 8 | 491 | 697 | $88,161 | $47,175 |
| 2021 | 5 | 217 | 291 | $37,982 | $19,135 |
| 2020 | 7 | 321 | 413 | $39,507 | $20,896 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 306 | $50,854 | $21,633 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 66 | $7,539 | $2,973 | 39.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 22 | 23 | $989.00 | $969.22 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 21 | $1,575 | $831.60 | 52.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 22 | $682.00 | $647.90 | 95.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 435 | $72,062 | $36,210 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 82 | $9,367 | $5,273 | 56.3% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 69 | 70 | $3,010 | $2,952 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 60 | $1,860 | $1,699 | 91.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 13 | $975.00 | $532.60 | 54.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $341.00 | $312.06 | 91.5% |
| 90471 | Administration of vaccine | Office | 2022 | 13 | 13 | $494.00 | $153.13 | 31.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 13 | $52.00 | $44.52 | 85.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 182 | $30,063 | $15,209 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 43 | $4,761 | $1,836 | 38.6% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 23 | 23 | $989.00 | $989.00 | 100.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 19 | $1,425 | $707.24 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 24 | 24 | $744.00 | $393.60 | 52.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 137 | 205 | $25,010 | $13,008 | 52.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 79 | $6,636 | $3,472 | 52.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 34 | 34 | $3,094 | $2,012 | 65.0% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 18 | 31 | $2,325 | $1,204 | 51.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 37 | 37 | $1,332 | $602.36 | 45.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 14 | $694.00 | $386.76 | 55.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $416.00 | $210.32 | 50.6% |
About Dr. Rita Camacho, MD
Dr. Rita Camacho, MD is a Family Medicine healthcare provider based in Somerset, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154334654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rita Camacho, MD has received a total of $2,152 in payments from pharmaceutical and medical device companies, with $118.73 received in 2019. These payments were reported across 207 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,126).
As a Medicare-enrolled provider, Camacho has provided services to 1,350 Medicare beneficiaries, totaling 1,839 services with total Medicare billing of $114,260. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Somerset, PA
- Active Since 08/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154334654
Products in Payments
- XARELTO (Drug) $225.27
- VIBERZI (Drug) $132.92
- ANORO (Drug) $115.61
- Prolia (Biological) $106.25
- INVOKANA (Drug) $103.91
- LINZESS (Drug) $84.24
- LYRICA (Drug) $81.21
- NAMZARIC (Drug) $81.02
- BREO (Drug) $69.76
- Victoza (Drug) $61.84
- Saxenda (Drug) $59.73
- ADVAIR (Drug) $54.69
- FARXIGA (Drug) $52.54
- Livalo (Drug) $50.56
- ENTRESTO (Drug) $45.17
- VIIBRYD (Drug) $42.54
- MYRBETRIQ (Drug) $36.48
- ELIQUIS (Drug) $35.99
- CHANTIX (Drug) $34.58
- BYDUREON (Drug) $31.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Somerset
Dr. Robert Drake, Md, MD
Family Medicine — Payments: $14,200
Jeffrey Vanmeter, M.d, M.D
Family Medicine — Payments: $14,143
Dr. Marlo Marcheleovich, D.o, D.O
Family Medicine — Payments: $9,217
Lana New
Family Medicine — Payments: $8,316
Christopher Lebo, D.o, D.O
Family Medicine — Payments: $7,165
Barbara Etheridge, M.d, M.D
Family Medicine — Payments: $4,585